Oramed Pharmaceuticals (XTAE:ORMP) Accounts Payable & Accrued Expense : ₪4.64 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Oramed Pharmaceuticals Accounts Payable & Accrued Expense?

Oramed Pharmaceuticals's quarterly accounts payable & accrued expense declined from Sep. 2023 (₪9.37 Mil) to Dec. 2023 (₪7.08 Mil) and declined from Dec. 2023 (₪7.08 Mil) to Mar. 2024 (₪4.64 Mil).

Oramed Pharmaceuticals's annual accounts payable & accrued expense increased from Aug. 2021 (₪14.07 Mil) to Dec. 2022 (₪15.22 Mil) but then declined from Dec. 2022 (₪15.22 Mil) to Dec. 2023 (₪7.08 Mil).

Oramed Pharmaceuticals Accounts Payable & Accrued Expense Historical Data

The historical data trend for Oramed Pharmaceuticals's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oramed Pharmaceuticals Accounts Payable & Accrued Expense Chart

Oramed Pharmaceuticals Annual Data

Trend

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

9.53

6.55

14.07

15.22

7.08

Oramed Pharmaceuticals Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															14.84	3.04	9.37	7.08	4.64

Oramed Pharmaceuticals Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Oramed Pharmaceuticals (XTAE:ORMP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oramed Pharmaceuticals Inc (XTAE:ORMP) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

ORMP:USA OJU1:Germany

Address

1185 Avenue of the Americas, Third Floor, New York, NY, USA, 10036

Website

https://www.oramed.com

Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas.